Drug intelligence / Profile preview

Sunho Meitong

Development stage
Unknown
Lead developer
Beijing Sunho
Modality
Small Molecules, Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

Sunho Meitong (Compound Digestive Enzyme Capsules) is an oral fixed-dose combination of digestive enzymes and a bile acid, developed by Beijing Sunho Pharmaceutical (and its subsidiary Guangdong Sunho) for the treatment of indigestion and lack of appetite. Each capsule contains pepsin, papain, amylase, ursodeoxycholic acid, cellulase, and pancreatin (which includes trypsin, pancreatic amylase, and pancreatic lipase). The formulation utilizes a segmented disintegration and localized release technology, allowing the different enzymes to release and function at their optimal pH levels in the gastrointestinal tract. Pepsin and papain break down proteins in the stomach; amylase digests carbohydrates; ursodeoxycholic acid promotes bile secretion and emulsifies fats; cellulase degrades plant cell walls; and pancreatin further digests proteins, fats, and starches in the small intestine.

Brand names
Sunho Meitong
Other names
Compound Digestive Enzyme Capsulescompound digestive enzymes
02

Targets

FXR (Farnesoid x-activated receptor)GPBAR1

Beyond the preview

Go deeper on Sunho Meitong.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sunho Meitong.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call